A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 54
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ICSI
Long Form : Interstitial Cystitis Symptom Index
No. Year Title Co-occurring Abbreviation
2020 Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome. IC/BPS, UP, VAS
2020 Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. IC/BPS, ICPI, VAS
2020 Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial. CI, HL, IC/BPS, ICPI, PUF, TUC, TUR, VAS
2020 Long-standing nonulcerative bladder pain syndrome: Impact of Thiele massage on bladder and sexual domains. FSFI, IC/BPS, ICPI, TM, VAS
2020 Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index. BPS/IC, ICPI, VAS
2019 Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia. IC, NP, VAS
2019 Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction? AVV, EC, IC, ICPI, MVV, TUF, VAS
2019 Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome. CS, FSFI, HA/CS, IC/BPS, ICPI, VAS
2019 The effect of Hydrodistension in combination with Pentosan Polysulfate on treatment outcomes and compliance in the treatment of bladder pain syndrome. BPS, FSFI, IC, ICPI, PPS, VAS
10  2019 [Efficacy of electroacupuncture nerve stimulation therapy for interstitial cystitis/bladder pain syndrome]. ENST, IC/PBS, ICPI, VAS
11  2018 A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome. CI, GRA, IC/BPS, ICPI, OR
12  2018 Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices. BT, HD, IC, ICPI
13  2018 Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis. BPS, GAG, IC, ICPI, PST, VAS
14  2018 Development of novel and non-invasive diagnostic markers for lower urinary tract symptoms using urothelial cells in voided urine. Cx, IC, LUTS, TRP
15  2018 Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia. ICPI
16  2018 Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study. BTX-A, IC/BPS, ICPI, VAS
17  2017 Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. ICPI
18  2017 Childhood bladder and bowel dysfunction predicts irritable bowel syndrome phenotype in adult interstitial cystitis/bladder pain syndrome patients. BBD, BBDQ, BM, IBS, IC/BPS, ICPI, PUF
19  2017 Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome. IC/BPS, ICPI, MVV, OSS, PUF, VAS
20  2017 Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. KAC
21  2017 Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome. CyA, HLs, IC-BPS
22  2017 Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study. IC/BPS, NGF
23  2016 A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis. ICPI
24  2016 A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome. ICPI
25  2016 Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: ARelook at the Role of Cystoscopy. ---
26  2016 Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies. BPS/IC, BTX-A, CI, ICPI, MCC, PVR, RCTs, WMD
27  2016 Microvascular Injury in Ketamine-Induced Bladder Dysfunction. BM, CBC, CD31, EM, FSP-1, ICPI, KC, NMDAR1, PLA
28  2016 Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network. ICPI
29  2016 Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome. CI, CS, HA, MD, VAS
30  2015 Prevalence of lower urinary tract symptoms and level of quality of life in men and women with chronic pelvic pain. CPPS, MPQ-DLV, MW-U, NIH-CPSI, PDI, PUF
31  2015 Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study. CS, GAG, HA, ICPI, PCa
32  2015 The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review. HA, ISPI, PBS/IC
33  2014 Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. FSFI, IC-BPS, UPOINT
34  2014 Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. HA, IC/BPS, ICPI, VAS
35  2014 Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis. BPS/IC, GAG, HA, HA-CS, ICPI, PST, VAS
36  2014 Multiple sensitivity phenotype in interstitial cystitis/bladder pain syndrome. IC/BPS, PUF, UPOINT
37  2014 Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome. HA, IC/PBS, PUF, VAS
38  2013 Health-related quality of life in patients with interstitial cystitis/bladder pain syndrome and frequently associated comorbidities. CFS, FM, HRQoL, IBS, IC/BPS, MCS, PCS
39  2013 [Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis]. IC, ICPI, MVV, VAS
40  2013 [Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis]. IC, ICPI, OPSI
41  2012 Contemporary management of the painful bladder: a systematic review. nRCTs, PBS/IC, RCTs, SMDs
42  2012 Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. GRA, IC/PBS, ICPI, VAS
43  2012 Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. IC/BPS
44  2011 Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. BPS, CIs, ORs
45  2011 [Experience in the treatment of interstitial cystitis: review of 17 cases]. DIMSO, IC, IC/BPS, ICPI
46  2010 Risk factors for poor sleep quality among patients with interstitial cystitis in Taiwan. HADS, NIDDK, PSQI
47  2009 Severity of interstitial cystitis symptoms and quality of life in female patients. IC, QOL, SF-36
48  2008 Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. IC, PPS
49  2008 Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. IC, ICPI, PPS
50  2007 Assessing urgency in interstitial cystitis/painful bladder syndrome. IC/PBS
51  2005 Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. IC, PORIS, PPS
52  2005 [The study of diagnosis and treatment of interstitial cystitis]. IC, NIDDK, PST
53  2004 Posterior tibial nerve stimulation in patients with intractable interstitial cystitis. ICPI, PPTNS
54  2001 Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. IC, ICC, PORIS, PPS